The RGTA® technology fosters tissue healing
and regeneration by Matrix Therapy
Cacipliq 20® belongs to the family of ReGeneraTing Agents (RGTA®), which are engineered biodegradable sugar based polymers.
Cacipliq 20® protects extracellular matrix proteins from the inside, hence restoring the matrix architecture. It preserves the natural cellular micro-environment of the wound and the endogenous factors needed for tissue regeneration.
Cacipliq 20® is a sterile wound healing solution.
Cacipliq 20® is a class III CE marked Medical Device.
Applied twice a week (every 3 to 4 days), Cacipliq 20® is a unique product which provides an easy-to-use, effective tissue regenerating solution for rapid wound healing.
Warnings and contraindications exist, please read the instructions.